Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
| ▸ | ACVR1 | Q04771 | 4/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | CDK4 | P11802 | 3/20 | 0.30 |
| ▸ | CCND1 | P24385 | 3/20 | 0.30 |
| ▸ | USP1 | O94782 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24310025 | 0.87 | TNK2 (0.35) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24310033 | 0.86 | LTA4H (0.32) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL29566830 | 0.85 | HTR6 (0.37) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL26811346 | 0.85 | HTR6 (0.37) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24310019 | 0.83 | LTA4H (0.39) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24309498 | 0.83 | ACVR1 (0.32) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24310026 | 0.83 | ACVR1 (0.32) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24310690 | 0.82 | PDE2A (0.34) | TNK2CDK1CCNA2EGFRCDK4 | |
| SCHEMBL24309744 | 0.81 | LTA4H (0.38) | LTA4HLCKJAK3BTKTNK2 | |
| SCHEMBL24310360 | 0.79 | KDM4E (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |